发布日期：2008.1.1

摘要

Countries covered: India

The global biotechnology industry in 2006 stood at USD73.12 billion up by 15.49% compared to 2005, the industry fared well in terms of fund raising, increased number of alliances and IPOs raised in the same period.Research and development activity, which is the foundation of success for the industry, is receiving continuous support all across the world with total R&D spend contributing to almost 38% of industry revenues.

The revenue of the Indian biotechnology industry reached INR85.41billion in 2006-07, up 30.98% from INR 65.21 billion in 2005-06. In 2006-07, top Ten Indian Companies reported revenue of INR 37.74 billion. The biotechnology industry is highly research and development (R&D) intensive. Globally, about 37.9% of revenue is spent on finding and developing new products. Although data relating to biotech R&D in India is not available, anecdotal evidence suggests that major companies are spending considerable amounts on biotech R&D, following their newfound focus on biotechnology.

The Report on indian biotechnology gives information on the core technologies in biotechnology with reference to bio processing, monoclonal antibody, bio-nanotechnology etc. Indian biotechnology report describes major clusters region wise. It provides information on the regulatory bodies and the regulations in biotech industry along with the regulatory structure. It helps in knowing the critical success factors in biotechnology industry with reference to mergers & Acquisitions, product portfolio etc. At the end the report gives a future outlook for biotechnology industry.

目录及图表

1.EXECUTIVE SUMMARY

3. BIOTECH INDUSTRY - GLOBAL OVERVIEW

3.1 Introduction

3.2 Industry growth

3.2.1 Concentric industry

3.2.2 Industry analysis

3.2.3 Research and development expenditure

3.2.5 Financial flow

3.3 Top ten biotech companies

4.1 Introduction

4.2 Milestones

4.3 The Indian Biotechnology Industry

4.3.1 Size

4.3.2 Industry segments

4.3.3 Exports

4.4 IPOs - Start of a new era

4.4.1 The price of success

4.5 Government Support

4.6 Funding

4.6.1 Government Funding

4.6.2 Private Funding

5. GROWTH DRIVERS

5.1 Introduction

5.2 Positive Regulatory Support

5.3 Availability of finance

5.4 Changing demographics & improved living standards

5.5 Growing Business Community

5.6 Growth of Related Industries

5.7 Knowledge Environment

5.8 Outsourcing

6. MAJOR PLAYERS

6.1 Serum Institute of India

6.2 Biocon

6.3 Panacea Biotech

6.4 Rasi Seeds

6.5 Venkateshwara Hatcheries

6.6 Aventis Pharma Limited

6.7 Glaxo Smithkline Pharmaceuticals

6.8 Shantha Biotechnics

6.9 Bharat Serums and Vaccines

6.10 Wockhardt

7. TECHNOLOGY

7.1 Core technologies

7.1.1 Bioprocessing

7.1.2 Monoclonal antibody

7.1.3 Cell/ tissue culture

7.1.4 Cloning

7.1.5 Recombinant DNA technology

7.1.6 Protein engineering

7.1.7 Biosensors

7.1.8 Bio-Nanotechnology

7.1.9 Microarrays

7.2 Other uses of biotechnology

7.3 Outlook

7.3.1 Pharmacogenomics

7.3.2 Metabolomics

7.3.4 Gene therapy

7.3.5 Immuno (Hybridoma) Technology

7.3.6 Stem cell techniques

7.3.7 Nutraceuticals

7.3.8 Bioremediation

7.3.9 Bioinformatics

8. MAJOR CLUSTERS

8.1 Southern Region

8.1.1 Andhra Pradesh-Hyderabad

8.1.2 Karnataka-Bangalore

8.1.3 Tamil Nadu-Chennai

8.2 Northern region

8.2.1 National Capital Region- Delhi

8.2.2 Uttar Pradesh (Lucknow) & Punjab (Chandigarh)

8.3 Western Region

8.3.1 Maharashtra-Mumbai & Pune

8.3.2 Gujarat

8.4 North Eastern Region

8.4.1 West Bengal-Kolkata

8.4.2 Assam- Gauhati

9. ISSUES AND CHALLENGES

9.1 Funding

9.2 Indian biotech start-ups & Foreign VCs

9.3 Biotech Manpower

9.4 Big pharma & biotechnology

9.5 Scientific community & Business acumen

9.6 Multiple regulators

10. REGULATIONS

10.1 Regulatory bodies

10.1.1 Organizational Structure of Relevant Institution

10.2 Regulatory Structure

10.3 Highlights of State Government Biotech Policies

10.3.1 Andhra Pradesh Biotech Policy

10.3.2 Maharashtra Biotech Policy

10.3.3 Gujarat Biotech Policy

10.3.4 Karnataka Biotech Policy

10.3.5 Tamil Nadu Biotech Policy

10.3.6 Himachal Pradesh Biotech Policy

10.3.7 Orissa Biotech Policy

11. CRITICAL SUCCESS FACTORS

11.1 Research & Development

11.2 Infrastructure

11.2.1 Premises and infrastructure

11.2.2 Biotech clusters

11.2.3 Effective networks

11.4 Mergers and Acquisitions

11.5 Product Portfolio

12. FUTURE OUTLOOK

ANNEXURE 1

ANNEXURE 2